Fundraising Fox

F-Prime Capital β€” 2020 Investments

6 investments dated 2020 Β· listed companies and verified rows first Β· show all

peerTransferNASDAQ: FLYWFeb 2020SEC filingmedium confidence

Boston, US

John Raguin(Director)Phillip Riese(Director)Matthew Harris(Director)Alex Finkelstein(Director)Pablo Ventura Aranguren(Director)Michael Massaro(Executive Officer, Director)

Board seatDavid JegenΒ· per SEC Form D Β· $171.1M raise Β· filed Feb 2020

Co-investorsKfund

Cytek Biosciencescytekbio.comin𝕏NASDAQ: CTKBOct 2020

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

Wenbin Jiang, Ph.D.(CEO and Chairman of the Board)Wenbin Jiang(Executive Officer, Director)Ming Yan, Ph.D.(Chief Technology Officer)Ming Yan(Executive Officer, Director)Jiecheng Zhang(Director)Allen Poirson(Director)

Co-investors3E Bioventures CapitalNorthern Light Venture Capital

Buoy Healthbuoyhealth.comin𝕏Nov 2020

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.

AI & Machine LearningDigital HealthHealthtechBoston, US

Andrew Le(Executive Officer, Director, Promoter)Andrew Le, MD(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)

Board seatCarl ByersΒ· per SEC Form D

Co-investorsEvolution VC PartnersTorch CapitalFundRxHumanaOptum VenturesWR Hambrecht

Tempest Therapeuticstempesttx.comFeb 2020

Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T cell therapies for autoimmune and oncology indications.

BiotechHealthtechBrisbane, US

Stephen Brady(Director)Matthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)Thomas Woiwode(Director)Geoffrey Nichol(Director)Thomas W. Dubensky(Executive Officer, Director)

Board seatRobert WeisskoffΒ· per SEC Form D

Co-investorsLAVLilly Asia VenturesNew Enterprise Associates (NEA)Quan CapitalRoche Venture Fund

Neo4jneo4j.comin𝕏Sep 2020

Neo4j develops a graph database and graph data platform used to build applications that leverage connected data, with products including AuraDB, Graph Data Science, and vector search for GraphRAG and GenAI use cases.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSan Mateo, US

Emil Eifrem(Co-Founder and CEO)inMichael Asher(Executive Officer)

BoardLars Nordwall(Executive Officer)inMichael Treskow(Director)Emanuel Lang(Director)Christian Jepsen(Director)

Co-investorsGV (Google Ventures)Inovia CapitalCreandumEurazeoDawn CapitalOne Peak+3 more

Spinwheelspinwheel.ioin𝕏Dec 2020

Spinwheel provides an API platform delivering real-time consumer credit data and embedded payments for lenders, personal finance managers, and debt management platforms.

AI & Machine LearningData & InfrastructureFintechFremont, US

Tushar Vaish(Executive Officer, Director)Tomas Campos(Executive Officer, Director)

PartnerDavid JegenΒ· led

Co-investorsCore Venture CapitalFikaQED Investors

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.